Global Digital Therapeutics for Psychiatric Illnesses Market Growth (Status and Outlook) 2026-2032
The global Digital Therapeutics for Psychiatric Illnesses market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Digital Therapeutics for Psychiatric Illnesses are software program-driven, evidence-based interventions for the treatment, management or prevention of psychiatric illnesses.
United States market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Digital Therapeutics for Psychiatric Illnesses players cover Pear Therapeutics, Akili Interactive, Big Health, Click Therapeutics, Orexo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Digital Therapeutics for Psychiatric Illnesses Industry Forecast” looks at past sales and reviews total world Digital Therapeutics for Psychiatric Illnesses sales in 2025, providing a comprehensive analysis by region and market sector of projected Digital Therapeutics for Psychiatric Illnesses sales for 2026 through 2032. With Digital Therapeutics for Psychiatric Illnesses sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Therapeutics for Psychiatric Illnesses industry.
This Insight Report provides a comprehensive analysis of the global Digital Therapeutics for Psychiatric Illnesses landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Therapeutics for Psychiatric Illnesses portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Digital Therapeutics for Psychiatric Illnesses market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Therapeutics for Psychiatric Illnesses and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Therapeutics for Psychiatric Illnesses.
This report presents a comprehensive overview, market shares, and growth opportunities of Digital Therapeutics for Psychiatric Illnesses market by product type, application, key players and key regions and countries.
Segmentation by Type:
Digital Therapeutics for Psychiatric Illnesses are software program-driven, evidence-based interventions for the treatment, management or prevention of psychiatric illnesses.
United States market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Digital Therapeutics for Psychiatric Illnesses players cover Pear Therapeutics, Akili Interactive, Big Health, Click Therapeutics, Orexo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Digital Therapeutics for Psychiatric Illnesses Industry Forecast” looks at past sales and reviews total world Digital Therapeutics for Psychiatric Illnesses sales in 2025, providing a comprehensive analysis by region and market sector of projected Digital Therapeutics for Psychiatric Illnesses sales for 2026 through 2032. With Digital Therapeutics for Psychiatric Illnesses sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Therapeutics for Psychiatric Illnesses industry.
This Insight Report provides a comprehensive analysis of the global Digital Therapeutics for Psychiatric Illnesses landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Therapeutics for Psychiatric Illnesses portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Digital Therapeutics for Psychiatric Illnesses market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Therapeutics for Psychiatric Illnesses and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Therapeutics for Psychiatric Illnesses.
This report presents a comprehensive overview, market shares, and growth opportunities of Digital Therapeutics for Psychiatric Illnesses market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Prevention
- Management
- Treatment
- Insomnia
- Depression
- Autistic
- Anxiety Disorder
- Schizophrenia
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pear Therapeutics
- Akili Interactive
- Big Health
- Click Therapeutics
- Orexo
- Limbix
- Cognoa
- Freespira
- Shandong Xindao Artificial Intelligence Technology Co., Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Digital Therapeutics for Psychiatric Illnesses Market Size (2021-2032)
2.1.2 Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Digital Therapeutics for Psychiatric Illnesses by Country/Region (2021, 2025 & 2032)
2.2 Digital Therapeutics for Psychiatric Illnesses Segment by Type
2.2.1 Prevention
2.2.2 Management
2.2.3 Treatment
2.2.4 Digital Therapeutics for Psychiatric Illnesses Market Size by Type
2.2.4.1 Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
2.3 Digital Therapeutics for Psychiatric Illnesses Segment by Application
2.3.1 Insomnia
2.3.2 Depression
2.3.3 Autistic
2.3.4 Anxiety Disorder
2.3.5 Schizophrenia
2.3.6 Other
2.3.7 Digital Therapeutics for Psychiatric Illnesses Market Size by Application
2.3.7.1 Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.7.2 Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
3 DIGITAL THERAPEUTICS FOR PSYCHIATRIC ILLNESSES MARKET SIZE BY PLAYER
3.1 Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Player
3.1.1 Global Digital Therapeutics for Psychiatric Illnesses Revenue by Player (2021-2026)
3.1.2 Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Player (2021-2026)
3.2 Global Digital Therapeutics for Psychiatric Illnesses Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DIGITAL THERAPEUTICS FOR PSYCHIATRIC ILLNESSES BY REGION
4.1 Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2021-2026)
4.2 Global Digital Therapeutics for Psychiatric Illnesses Annual Revenue by Country/Region (2021-2026)
4.3 Americas Digital Therapeutics for Psychiatric Illnesses Market Size Growth (2021-2026)
4.4 APAC Digital Therapeutics for Psychiatric Illnesses Market Size Growth (2021-2026)
4.5 Europe Digital Therapeutics for Psychiatric Illnesses Market Size Growth (2021-2026)
4.6 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2021-2026)
5.2 Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026)
5.3 Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2021-2026)
6.2 APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026)
6.3 APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2021-2026)
7.2 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026)
7.3 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses by Region (2021-2026)
8.2 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026)
8.3 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DIGITAL THERAPEUTICS FOR PSYCHIATRIC ILLNESSES MARKET FORECAST
10.1 Global Digital Therapeutics for Psychiatric Illnesses Forecast by Region (2027-2032)
10.1.1 Global Digital Therapeutics for Psychiatric Illnesses Forecast by Region (2027-2032)
10.1.2 Americas Digital Therapeutics for Psychiatric Illnesses Forecast
10.1.3 APAC Digital Therapeutics for Psychiatric Illnesses Forecast
10.1.4 Europe Digital Therapeutics for Psychiatric Illnesses Forecast
10.1.5 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Forecast
10.2 Americas Digital Therapeutics for Psychiatric Illnesses Forecast by Country (2027-2032)
10.2.1 United States Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.2.2 Canada Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.2.3 Mexico Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.2.4 Brazil Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.3 APAC Digital Therapeutics for Psychiatric Illnesses Forecast by Region (2027-2032)
10.3.1 China Digital Therapeutics for Psychiatric Illnesses Market Forecast
10.3.2 Japan Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.3.3 Korea Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.3.4 Southeast Asia Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.3.5 India Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.3.6 Australia Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.4 Europe Digital Therapeutics for Psychiatric Illnesses Forecast by Country (2027-2032)
10.4.1 Germany Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.4.2 France Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.4.3 UK Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.4.4 Italy Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.4.5 Russia Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.5 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Forecast by Region (2027-2032)
10.5.1 Egypt Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.5.2 South Africa Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.5.3 Israel Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.5.4 Turkey Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.6 Global Digital Therapeutics for Psychiatric Illnesses Forecast by Type (2027-2032)
10.7 Global Digital Therapeutics for Psychiatric Illnesses Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Digital Therapeutics for Psychiatric Illnesses Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pear Therapeutics
11.1.1 Pear Therapeutics Company Information
11.1.2 Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Product Offered
11.1.3 Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pear Therapeutics Main Business Overview
11.1.5 Pear Therapeutics Latest Developments
11.2 Akili Interactive
11.2.1 Akili Interactive Company Information
11.2.2 Akili Interactive Digital Therapeutics for Psychiatric Illnesses Product Offered
11.2.3 Akili Interactive Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Akili Interactive Main Business Overview
11.2.5 Akili Interactive Latest Developments
11.3 Big Health
11.3.1 Big Health Company Information
11.3.2 Big Health Digital Therapeutics for Psychiatric Illnesses Product Offered
11.3.3 Big Health Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Big Health Main Business Overview
11.3.5 Big Health Latest Developments
11.4 Click Therapeutics
11.4.1 Click Therapeutics Company Information
11.4.2 Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Product Offered
11.4.3 Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Click Therapeutics Main Business Overview
11.4.5 Click Therapeutics Latest Developments
11.5 Orexo
11.5.1 Orexo Company Information
11.5.2 Orexo Digital Therapeutics for Psychiatric Illnesses Product Offered
11.5.3 Orexo Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Orexo Main Business Overview
11.5.5 Orexo Latest Developments
11.6 Limbix
11.6.1 Limbix Company Information
11.6.2 Limbix Digital Therapeutics for Psychiatric Illnesses Product Offered
11.6.3 Limbix Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Limbix Main Business Overview
11.6.5 Limbix Latest Developments
11.7 Cognoa
11.7.1 Cognoa Company Information
11.7.2 Cognoa Digital Therapeutics for Psychiatric Illnesses Product Offered
11.7.3 Cognoa Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cognoa Main Business Overview
11.7.5 Cognoa Latest Developments
11.8 Freespira
11.8.1 Freespira Company Information
11.8.2 Freespira Digital Therapeutics for Psychiatric Illnesses Product Offered
11.8.3 Freespira Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Freespira Main Business Overview
11.8.5 Freespira Latest Developments
11.9 Shandong Xindao Artificial Intelligence Technology Co., Ltd.
11.9.1 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Company Information
11.9.2 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Product Offered
11.9.3 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Main Business Overview
11.9.5 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Digital Therapeutics for Psychiatric Illnesses Market Size (2021-2032)
2.1.2 Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Digital Therapeutics for Psychiatric Illnesses by Country/Region (2021, 2025 & 2032)
2.2 Digital Therapeutics for Psychiatric Illnesses Segment by Type
2.2.1 Prevention
2.2.2 Management
2.2.3 Treatment
2.2.4 Digital Therapeutics for Psychiatric Illnesses Market Size by Type
2.2.4.1 Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
2.3 Digital Therapeutics for Psychiatric Illnesses Segment by Application
2.3.1 Insomnia
2.3.2 Depression
2.3.3 Autistic
2.3.4 Anxiety Disorder
2.3.5 Schizophrenia
2.3.6 Other
2.3.7 Digital Therapeutics for Psychiatric Illnesses Market Size by Application
2.3.7.1 Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.7.2 Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
3 DIGITAL THERAPEUTICS FOR PSYCHIATRIC ILLNESSES MARKET SIZE BY PLAYER
3.1 Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Player
3.1.1 Global Digital Therapeutics for Psychiatric Illnesses Revenue by Player (2021-2026)
3.1.2 Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Player (2021-2026)
3.2 Global Digital Therapeutics for Psychiatric Illnesses Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DIGITAL THERAPEUTICS FOR PSYCHIATRIC ILLNESSES BY REGION
4.1 Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2021-2026)
4.2 Global Digital Therapeutics for Psychiatric Illnesses Annual Revenue by Country/Region (2021-2026)
4.3 Americas Digital Therapeutics for Psychiatric Illnesses Market Size Growth (2021-2026)
4.4 APAC Digital Therapeutics for Psychiatric Illnesses Market Size Growth (2021-2026)
4.5 Europe Digital Therapeutics for Psychiatric Illnesses Market Size Growth (2021-2026)
4.6 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2021-2026)
5.2 Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026)
5.3 Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2021-2026)
6.2 APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026)
6.3 APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2021-2026)
7.2 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026)
7.3 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses by Region (2021-2026)
8.2 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026)
8.3 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DIGITAL THERAPEUTICS FOR PSYCHIATRIC ILLNESSES MARKET FORECAST
10.1 Global Digital Therapeutics for Psychiatric Illnesses Forecast by Region (2027-2032)
10.1.1 Global Digital Therapeutics for Psychiatric Illnesses Forecast by Region (2027-2032)
10.1.2 Americas Digital Therapeutics for Psychiatric Illnesses Forecast
10.1.3 APAC Digital Therapeutics for Psychiatric Illnesses Forecast
10.1.4 Europe Digital Therapeutics for Psychiatric Illnesses Forecast
10.1.5 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Forecast
10.2 Americas Digital Therapeutics for Psychiatric Illnesses Forecast by Country (2027-2032)
10.2.1 United States Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.2.2 Canada Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.2.3 Mexico Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.2.4 Brazil Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.3 APAC Digital Therapeutics for Psychiatric Illnesses Forecast by Region (2027-2032)
10.3.1 China Digital Therapeutics for Psychiatric Illnesses Market Forecast
10.3.2 Japan Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.3.3 Korea Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.3.4 Southeast Asia Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.3.5 India Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.3.6 Australia Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.4 Europe Digital Therapeutics for Psychiatric Illnesses Forecast by Country (2027-2032)
10.4.1 Germany Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.4.2 France Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.4.3 UK Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.4.4 Italy Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.4.5 Russia Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.5 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Forecast by Region (2027-2032)
10.5.1 Egypt Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.5.2 South Africa Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.5.3 Israel Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.5.4 Turkey Market Digital Therapeutics for Psychiatric Illnesses Forecast
10.6 Global Digital Therapeutics for Psychiatric Illnesses Forecast by Type (2027-2032)
10.7 Global Digital Therapeutics for Psychiatric Illnesses Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Digital Therapeutics for Psychiatric Illnesses Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pear Therapeutics
11.1.1 Pear Therapeutics Company Information
11.1.2 Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Product Offered
11.1.3 Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pear Therapeutics Main Business Overview
11.1.5 Pear Therapeutics Latest Developments
11.2 Akili Interactive
11.2.1 Akili Interactive Company Information
11.2.2 Akili Interactive Digital Therapeutics for Psychiatric Illnesses Product Offered
11.2.3 Akili Interactive Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Akili Interactive Main Business Overview
11.2.5 Akili Interactive Latest Developments
11.3 Big Health
11.3.1 Big Health Company Information
11.3.2 Big Health Digital Therapeutics for Psychiatric Illnesses Product Offered
11.3.3 Big Health Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Big Health Main Business Overview
11.3.5 Big Health Latest Developments
11.4 Click Therapeutics
11.4.1 Click Therapeutics Company Information
11.4.2 Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Product Offered
11.4.3 Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Click Therapeutics Main Business Overview
11.4.5 Click Therapeutics Latest Developments
11.5 Orexo
11.5.1 Orexo Company Information
11.5.2 Orexo Digital Therapeutics for Psychiatric Illnesses Product Offered
11.5.3 Orexo Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Orexo Main Business Overview
11.5.5 Orexo Latest Developments
11.6 Limbix
11.6.1 Limbix Company Information
11.6.2 Limbix Digital Therapeutics for Psychiatric Illnesses Product Offered
11.6.3 Limbix Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Limbix Main Business Overview
11.6.5 Limbix Latest Developments
11.7 Cognoa
11.7.1 Cognoa Company Information
11.7.2 Cognoa Digital Therapeutics for Psychiatric Illnesses Product Offered
11.7.3 Cognoa Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cognoa Main Business Overview
11.7.5 Cognoa Latest Developments
11.8 Freespira
11.8.1 Freespira Company Information
11.8.2 Freespira Digital Therapeutics for Psychiatric Illnesses Product Offered
11.8.3 Freespira Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Freespira Main Business Overview
11.8.5 Freespira Latest Developments
11.9 Shandong Xindao Artificial Intelligence Technology Co., Ltd.
11.9.1 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Company Information
11.9.2 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Product Offered
11.9.3 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Main Business Overview
11.9.5 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Digital Therapeutics for Psychiatric Illnesses Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prevention
Table 4. Major Players of Management
Table 5. Major Players of Treatment
Table 6. Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
Table 9. Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
Table 12. Global Digital Therapeutics for Psychiatric Illnesses Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Player (2021-2026)
Table 14. Digital Therapeutics for Psychiatric Illnesses Key Players Head office and Products Offered
Table 15. Digital Therapeutics for Psychiatric Illnesses Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Region (2021-2026)
Table 20. Global Digital Therapeutics for Psychiatric Illnesses Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Country (2021-2026)
Table 24. Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
Table 26. Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
Table 28. APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Region (2021-2026)
Table 30. APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Country (2021-2026)
Table 34. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Digital Therapeutics for Psychiatric Illnesses
Table 40. Key Market Challenges & Risks of Digital Therapeutics for Psychiatric Illnesses
Table 41. Key Industry Trends of Digital Therapeutics for Psychiatric Illnesses
Table 42. Global Digital Therapeutics for Psychiatric Illnesses Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Digital Therapeutics for Psychiatric Illnesses Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Digital Therapeutics for Psychiatric Illnesses Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Pear Therapeutics Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 47. Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 48. Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Pear Therapeutics Main Business
Table 50. Pear Therapeutics Latest Developments
Table 51. Akili Interactive Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 52. Akili Interactive Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 53. Akili Interactive Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Akili Interactive Main Business
Table 55. Akili Interactive Latest Developments
Table 56. Big Health Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 57. Big Health Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 58. Big Health Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Big Health Main Business
Table 60. Big Health Latest Developments
Table 61. Click Therapeutics Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 62. Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 63. Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Click Therapeutics Main Business
Table 65. Click Therapeutics Latest Developments
Table 66. Orexo Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 67. Orexo Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 68. Orexo Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Orexo Main Business
Table 70. Orexo Latest Developments
Table 71. Limbix Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 72. Limbix Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 73. Limbix Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Limbix Main Business
Table 75. Limbix Latest Developments
Table 76. Cognoa Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 77. Cognoa Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 78. Cognoa Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Cognoa Main Business
Table 80. Cognoa Latest Developments
Table 81. Freespira Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 82. Freespira Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 83. Freespira Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Freespira Main Business
Table 85. Freespira Latest Developments
Table 86. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 87. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 88. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Main Business
Table 90. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Latest Developments
Table 1. Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Digital Therapeutics for Psychiatric Illnesses Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Prevention
Table 4. Major Players of Management
Table 5. Major Players of Treatment
Table 6. Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
Table 9. Digital Therapeutics for Psychiatric Illnesses Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
Table 12. Global Digital Therapeutics for Psychiatric Illnesses Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Player (2021-2026)
Table 14. Digital Therapeutics for Psychiatric Illnesses Key Players Head office and Products Offered
Table 15. Digital Therapeutics for Psychiatric Illnesses Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Region (2021-2026)
Table 20. Global Digital Therapeutics for Psychiatric Illnesses Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Country (2021-2026)
Table 24. Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
Table 26. Americas Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
Table 28. APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Region (2021-2026)
Table 30. APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Country (2021-2026)
Table 34. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Digital Therapeutics for Psychiatric Illnesses
Table 40. Key Market Challenges & Risks of Digital Therapeutics for Psychiatric Illnesses
Table 41. Key Industry Trends of Digital Therapeutics for Psychiatric Illnesses
Table 42. Global Digital Therapeutics for Psychiatric Illnesses Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Digital Therapeutics for Psychiatric Illnesses Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Digital Therapeutics for Psychiatric Illnesses Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Pear Therapeutics Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 47. Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 48. Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Pear Therapeutics Main Business
Table 50. Pear Therapeutics Latest Developments
Table 51. Akili Interactive Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 52. Akili Interactive Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 53. Akili Interactive Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Akili Interactive Main Business
Table 55. Akili Interactive Latest Developments
Table 56. Big Health Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 57. Big Health Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 58. Big Health Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Big Health Main Business
Table 60. Big Health Latest Developments
Table 61. Click Therapeutics Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 62. Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 63. Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Click Therapeutics Main Business
Table 65. Click Therapeutics Latest Developments
Table 66. Orexo Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 67. Orexo Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 68. Orexo Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Orexo Main Business
Table 70. Orexo Latest Developments
Table 71. Limbix Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 72. Limbix Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 73. Limbix Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Limbix Main Business
Table 75. Limbix Latest Developments
Table 76. Cognoa Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 77. Cognoa Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 78. Cognoa Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Cognoa Main Business
Table 80. Cognoa Latest Developments
Table 81. Freespira Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 82. Freespira Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 83. Freespira Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Freespira Main Business
Table 85. Freespira Latest Developments
Table 86. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Details, Company Type, Digital Therapeutics for Psychiatric Illnesses Area Served and Its Competitors
Table 87. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Product Offered
Table 88. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Main Business
Table 90. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Digital Therapeutics for Psychiatric Illnesses Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Digital Therapeutics for Psychiatric Illnesses Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Digital Therapeutics for Psychiatric Illnesses Sales Market Share by Country/Region (2025)
Figure 8. Digital Therapeutics for Psychiatric Illnesses Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type in 2025
Figure 10. Digital Therapeutics for Psychiatric Illnesses in Insomnia
Figure 11. Global Digital Therapeutics for Psychiatric Illnesses Market: Insomnia (2021-2026) & ($ millions)
Figure 12. Digital Therapeutics for Psychiatric Illnesses in Depression
Figure 13. Global Digital Therapeutics for Psychiatric Illnesses Market: Depression (2021-2026) & ($ millions)
Figure 14. Digital Therapeutics for Psychiatric Illnesses in Autistic
Figure 15. Global Digital Therapeutics for Psychiatric Illnesses Market: Autistic (2021-2026) & ($ millions)
Figure 16. Digital Therapeutics for Psychiatric Illnesses in Anxiety Disorder
Figure 17. Global Digital Therapeutics for Psychiatric Illnesses Market: Anxiety Disorder (2021-2026) & ($ millions)
Figure 18. Digital Therapeutics for Psychiatric Illnesses in Schizophrenia
Figure 19. Global Digital Therapeutics for Psychiatric Illnesses Market: Schizophrenia (2021-2026) & ($ millions)
Figure 20. Digital Therapeutics for Psychiatric Illnesses in Other
Figure 21. Global Digital Therapeutics for Psychiatric Illnesses Market: Other (2021-2026) & ($ millions)
Figure 22. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application in 2025
Figure 23. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Player in 2025
Figure 24. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Region (2021-2026)
Figure 25. Americas Digital Therapeutics for Psychiatric Illnesses Market Size 2021-2026 ($ millions)
Figure 26. APAC Digital Therapeutics for Psychiatric Illnesses Market Size 2021-2026 ($ millions)
Figure 27. Europe Digital Therapeutics for Psychiatric Illnesses Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size 2021-2026 ($ millions)
Figure 29. Americas Digital Therapeutics for Psychiatric Illnesses Value Market Share by Country in 2025
Figure 30. United States Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Region in 2025
Figure 35. APAC Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
Figure 36. APAC Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
Figure 37. China Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 41. India Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Country in 2025
Figure 44. Europe Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
Figure 45. Europe Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
Figure 46. Germany Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 47. France Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 60. APAC Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 61. Europe Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 63. United States Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 64. Canada Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 65. Mexico Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 66. Brazil Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 67. China Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 68. Japan Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 69. Korea Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 71. India Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 72. Australia Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 73. Germany Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 74. France Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 75. UK Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 76. Italy Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 77. Russia Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 78. Egypt Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 79. South Africa Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 80. Israel Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 81. Turkey Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 82. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 1. Digital Therapeutics for Psychiatric Illnesses Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Digital Therapeutics for Psychiatric Illnesses Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Digital Therapeutics for Psychiatric Illnesses Sales Market Share by Country/Region (2025)
Figure 8. Digital Therapeutics for Psychiatric Illnesses Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type in 2025
Figure 10. Digital Therapeutics for Psychiatric Illnesses in Insomnia
Figure 11. Global Digital Therapeutics for Psychiatric Illnesses Market: Insomnia (2021-2026) & ($ millions)
Figure 12. Digital Therapeutics for Psychiatric Illnesses in Depression
Figure 13. Global Digital Therapeutics for Psychiatric Illnesses Market: Depression (2021-2026) & ($ millions)
Figure 14. Digital Therapeutics for Psychiatric Illnesses in Autistic
Figure 15. Global Digital Therapeutics for Psychiatric Illnesses Market: Autistic (2021-2026) & ($ millions)
Figure 16. Digital Therapeutics for Psychiatric Illnesses in Anxiety Disorder
Figure 17. Global Digital Therapeutics for Psychiatric Illnesses Market: Anxiety Disorder (2021-2026) & ($ millions)
Figure 18. Digital Therapeutics for Psychiatric Illnesses in Schizophrenia
Figure 19. Global Digital Therapeutics for Psychiatric Illnesses Market: Schizophrenia (2021-2026) & ($ millions)
Figure 20. Digital Therapeutics for Psychiatric Illnesses in Other
Figure 21. Global Digital Therapeutics for Psychiatric Illnesses Market: Other (2021-2026) & ($ millions)
Figure 22. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application in 2025
Figure 23. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Player in 2025
Figure 24. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Region (2021-2026)
Figure 25. Americas Digital Therapeutics for Psychiatric Illnesses Market Size 2021-2026 ($ millions)
Figure 26. APAC Digital Therapeutics for Psychiatric Illnesses Market Size 2021-2026 ($ millions)
Figure 27. Europe Digital Therapeutics for Psychiatric Illnesses Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size 2021-2026 ($ millions)
Figure 29. Americas Digital Therapeutics for Psychiatric Illnesses Value Market Share by Country in 2025
Figure 30. United States Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Region in 2025
Figure 35. APAC Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
Figure 36. APAC Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
Figure 37. China Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 41. India Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Country in 2025
Figure 44. Europe Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
Figure 45. Europe Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
Figure 46. Germany Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 47. France Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Digital Therapeutics for Psychiatric Illnesses Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 60. APAC Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 61. Europe Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 63. United States Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 64. Canada Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 65. Mexico Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 66. Brazil Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 67. China Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 68. Japan Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 69. Korea Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 71. India Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 72. Australia Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 73. Germany Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 74. France Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 75. UK Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 76. Italy Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 77. Russia Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 78. Egypt Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 79. South Africa Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 80. Israel Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 81. Turkey Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
Figure 82. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Digital Therapeutics for Psychiatric Illnesses Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Digital Therapeutics for Psychiatric Illnesses Market Size 2027-2032 ($ millions)
